Finance

Lists
AKBA:NASDAQ
Akebia Therapeutics Inc
0,80 $
-1,68%
(-0,014) 1D
0,81 $
+0,80% (+0,0064)
After hours
Closed: 9 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AKBA...
Open
0,82 $
High
0,83 $
Low
0,80 $
Mkt. cap
223,31 մլն
Avg. vol.
7,54 մլն
Volume
6,09 մլն
52-wk high
3,18 $
52-wk low
0,80 $
EPS
-0,11 $
Beta
0,18
Shares outstanding
277,11 մլն
No. of employees
194
Open
0,82 $
High
0,83 $
Low
0,80 $
Mkt. cap
223,31 մլն
Avg. vol.
7,54 մլն
Volume
6,09 մլն
52-wk high
3,18 $
52-wk low
0,80 $
EPS
-0,11 $
Beta
0,18
Shares outstanding
277,11 մլն
No. of employees
194
News stories
From web sources and news partners
About Akebia Therapeutics Inc
CEO-
Employees194
Founded01 հնվ, 2007 թ.
HeadquartersՔեմբրիջ, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websiteakebia.com
Analyst ratings
Based on 5 analysts giving stock ratings to AKBA in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for AKBA in the last 3 months.
Highest
Current 0,80 $
6,00 $ (+648,97%)
Average
3,90 $ (+386,83%)
Lowest
1,00 $ (+24,83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Julian Harrison
BTIG
Buy
Maintained
4,00 $
+399,3%
09/14/2026
Ed Arce
Westpark Capital
Buy
Initiated
4,50 $
+461,7%
09/08/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
4,00 $
+399,3%
08/17/2026
Roanna Ruiz
Leerink Partners
Hold
Downgraded
1,00 $
+24,8%
08/07/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
6,00 $
+649%
08/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
58,77 մլն
57,62 մլն
53,54 մլն
49,13 մլն
Cost of goods sold
10,28 մլն
10,93 մլն
9,78 մլն
9,58 մլն
Cost of revenue
10,28 մլն
10,93 մլն
9,78 մլն
9,58 մլն
Research and development expenses
14,94 մլն
26,65 մլն
14,81 մլն
14,06 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29,09 մլն
26,09 մլն
30,44 մլն
28,17 մլն
Operating expense
44,04 մլն
52,74 մլն
45,24 մլն
42,23 մլն
Total operating expenses
54,32 մլն
63,67 մլն
55,02 մլն
51,81 մլն
Operating income
4,45 մլն
-6,05 մլն
-1,48 մլն
-2,68 մլն
Other non operating income
1,45 մլն
2,14 մլն
459,00 հզր
559,00 հզր
EBT including unusual items
1,16 մլն
-11,24 մլն
-8,93 մլն
-8,84 մլն
EBT excluding unusual items
1,16 մլն
-8,73 մլն
-5,71 մլն
-5,19 մլն
Income tax expense
615,00 հզր
1,01 մլն
126,00 հզր
70,00 հզր
Effective tax rate
53,25%
-8,98%
-1,41%
-0,79%
Other operating expenses
-
-
-
-
Net income
540,00 հզր
-12,24 մլն
-9,05 մլն
-8,91 մլն
Net profit margin
0,92%
-21,25%
-16,91%
-18,13%
Earnings per share
-
-0,05
-0,03
-0,03
Interest and investment income
-
-
-
-
Interest expense
-4,75 մլն
-4,83 մլն
-4,69 մլն
-3,07 մլն
Net interest expenses
-4,75 մլն
-4,83 մլն
-4,69 մլն
-3,07 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
4,77 մլն
-5,73 մլն
-1,15 մլն
-2,10 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps